These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30138849)

  • 1. Integration-free reprogramming of human umbilical arterial endothelial cells into induced pluripotent stem cells IHSTMi001-A.
    Li H; Pei H; Nie J; Qu M; Fan Z; Jia Y; He L; Nan X; Yue W; Pei X
    Stem Cell Res; 2018 Aug; 31():231-234. PubMed ID: 30138849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential Hematopoietic Differentiation in Induced Pluripotent Stem Cells Derived From Human Umbilical Cord Arterial Endothelial Cells.
    Pei H; Li H; Xu L; Zhang B; Zhang H; Jia Y; Liang L; Xie X; Fan Z; Yang Z; Wang X; Song F; He L; Yue W; Pei X
    Arterioscler Thromb Vasc Biol; 2023 May; 43(5):697-712. PubMed ID: 36951064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα.
    Bueno C; Sardina JL; Di Stefano B; Romero-Moya D; Muñoz-López A; Ariza L; Chillón MC; Balanzategui A; Castaño J; Herreros A; Fraga MF; Fernández A; Granada I; Quintana-Bustamante O; Segovia JC; Nishimura K; Ohtaka M; Nakanishi M; Graf T; Menendez P
    Leukemia; 2016 Mar; 30(3):674-82. PubMed ID: 26500142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4.
    Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y
    Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient Generation of Non-Integration and Feeder-Free Induced Pluripotent Stem Cells from Human Peripheral Blood Cells by Sendai Virus.
    Ye H; Wang Q
    Cell Physiol Biochem; 2018; 50(4):1318-1331. PubMed ID: 30355953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
    Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
    Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors.
    Löhle M; Hermann A; Glass H; Kempe A; Schwarz SC; Kim JB; Poulet C; Ravens U; Schwarz J; Schöler HR; Storch A
    Stem Cells; 2012 Mar; 30(3):570-9. PubMed ID: 22213586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivation of Endogenous Genes and Epigenetic Remodeling Are Barriers for Generating Transgene-Free Induced Pluripotent Stem Cells in Pig.
    Choi KH; Park JK; Son D; Hwang JY; Lee DK; Ka H; Park J; Lee CK
    PLoS One; 2016; 11(6):e0158046. PubMed ID: 27336671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-specific cardiovascular progenitor cells derived from integration-free induced pluripotent stem cells for vascular tissue regeneration.
    Hu J; Wang Y; Jiao J; Liu Z; Zhao C; Zhou Z; Zhang Z; Forde K; Wang L; Wang J; Baylink DJ; Zhang XB; Gao S; Yang B; Chen YE; Ma PX
    Biomaterials; 2015 Dec; 73():51-9. PubMed ID: 26398309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
    Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feeder-independent derivation of induced-pluripotent stem cells from peripheral blood endothelial progenitor cells.
    Chang WY; Lavoie JR; Kwon SY; Chen Z; Manias JL; Behbahani J; Ling V; Kandel RA; Stewart DJ; Stanford WL
    Stem Cell Res; 2013 Mar; 10(2):195-202. PubMed ID: 23291290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a human iPSC line by mRNA reprogramming.
    Artero Castro A; León M; Del Buey Furió V; Erceg S; Lukovic D
    Stem Cell Res; 2018 Apr; 28():157-160. PubMed ID: 29499498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions.
    Rodríguez-Pizà I; Richaud-Patin Y; Vassena R; González F; Barrero MJ; Veiga A; Raya A; Izpisúa Belmonte JC
    Stem Cells; 2010 Jan; 28(1):36-44. PubMed ID: 19890879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manipulation of KLF4 expression generates iPSCs paused at successive stages of reprogramming.
    Nishimura K; Kato T; Chen C; Oinam L; Shiomitsu E; Ayakawa D; Ohtaka M; Fukuda A; Nakanishi M; Hisatake K
    Stem Cell Reports; 2014 Nov; 3(5):915-29. PubMed ID: 25418733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels.
    Margariti A; Winkler B; Karamariti E; Zampetaki A; Tsai TN; Baban D; Ragoussis J; Huang Y; Han JD; Zeng L; Hu Y; Xu Q
    Proc Natl Acad Sci U S A; 2012 Aug; 109(34):13793-8. PubMed ID: 22869753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells.
    Li HY; Chien Y; Chen YJ; Chen SF; Chang YL; Chiang CH; Jeng SY; Chang CM; Wang ML; Chen LK; Hung SI; Huo TI; Lee SD; Chiou SH
    Biomaterials; 2011 Sep; 32(26):5994-6005. PubMed ID: 21658760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of a human control iPS cell line (ESi080-A) from a donor with no rheumatic diseases.
    Castro-Viñuelas R; Sanjurjo-Rodríguez C; Piñeiro-Ramil M; Rodríguez-Fernández S; Fuentes-Boquete IM; Blanco FJ; Díaz-Prado SM
    Stem Cell Res; 2020 Mar; 43():101683. PubMed ID: 31962233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced pluripotent stem cells reprogrammed from primary dendritic cells provide an abundant source of immunostimulatory dendritic cells for use in immunotherapy.
    Horton C; Davies TJ; Lahiri P; Sachamitr P; Fairchild PJ
    Stem Cells; 2020 Jan; 38(1):67-79. PubMed ID: 31621975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generating iPSC-Derived Choroidal Endothelial Cells to Study Age-Related Macular Degeneration.
    Songstad AE; Wiley LA; Duong K; Kaalberg E; Flamme-Wiese MJ; Cranston CM; Riker MJ; Levasseur D; Stone EM; Mullins RF; Tucker BA
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):8258-67. PubMed ID: 26720480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced OCT4 transcriptional activity substitutes for exogenous SOX2 in cellular reprogramming.
    Marthaler AG; Adachi K; Tiemann U; Wu G; Sabour D; Velychko S; Kleiter I; Schöler HR; Tapia N
    Sci Rep; 2016 Jan; 6():19415. PubMed ID: 26762895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.